Policy | October 27, 2021
PLI scheme has the potential to make India a pharma hub: Dr Mandaviya
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
Second interchangeable biosimilar product approved by agency
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
U.S. FDA to decide whether to authorize a booster dose in the coming days
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
Subscribe To Our Newsletter & Stay Updated
